Provided by Tiger Fintech (Singapore) Pte. Ltd.

CRISPR Therapeutics AG

39.55
+1.734.56%
Volume:937.69K
Turnover:36.83M
Market Cap:3.39B
PE:-9.11
High:39.85
Open:38.49
Low:38.34
Close:37.82
Loading ...

Medical AI Stocks Soar; CRISPR Rises 16%; Recursion Pharma Jumps 14%; Tempus AI up 5%

Tiger Newspress
·
14 Feb

CRISPR Therapeutics Ag : Morgan Stanley Raises Target Price to $32.00 From $30.00

THOMSON REUTERS
·
14 Feb

Crispr Therapeutics AG (CRSP) Gets a Sell from Morgan Stanley

TIPRANKS
·
14 Feb

Crispr Therapeutics Raised to Outperform From In-Line by Evercore ISI Group

Dow Jones
·
14 Feb

CRISPR Therapeutics Reports 2024 Results and Clinical Progress

TIPRANKS
·
14 Feb

Crispr Therapeutics Is Maintained at Hold by Stifel

Dow Jones
·
13 Feb

Crispr Therapeutics price target lowered to $49 from $53 at Stifel

TIPRANKS
·
13 Feb

Crispr Therapeutics Price Target Maintained With a $65.00/Share by HC Wainwright & Co.

Dow Jones
·
13 Feb

Crispr Therapeutics Faces Market Challenges Amidst BPCIA Biosimilar Risks

TIPRANKS
·
13 Feb

Crispr Therapeutics AG: Advancements and Strategic Partnerships Justify Buy Rating

TIPRANKS
·
13 Feb

Analysts Offer Insights on Healthcare Companies: Rezolute (RZLT) and Crispr Therapeutics AG (CRSP)

TIPRANKS
·
13 Feb

Crispr Therapeutics AG (CRSP) Receives a Buy from Chardan Capital

TIPRANKS
·
13 Feb

Why CRISPR Therapeutics Stock Was a Massive Winner on Wednesday

Motley Fool
·
13 Feb

Crispr Therapeutics price target raised to $86 from $85 at BofA

TipRanks
·
12 Feb

CRISPR Therapeutics Q4 Earnings and Revenues Surpass Estimates

Zacks
·
12 Feb

Crispr Therapeutics price target lowered to $48 from $53 at RBC Capital

TIPRANKS
·
12 Feb

Crispr Therapeutics price target raised to $120 from $100 at Truist

TIPRANKS
·
12 Feb

CRISPR Therapeutics Ag : TD Cowen Raises to Hold From Sell

THOMSON REUTERS
·
12 Feb

RBC Lowers Price Target on CRISPR Therapeutics to $48 From $53, Keeps Sector Perform, Speculative Risk

MT Newswires Live
·
12 Feb

CRISPR Therapeutics Ag : Leerink Partners Cuts Target Price to $65 From $67

THOMSON REUTERS
·
12 Feb